Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Agilent Technologies (A)

NYSE: A · Diagnostics & Research · Santa Clara, CA

Our rating: Neutral

Neutral reaffirmed at $181.15, moderate conviction, October 29, 2026.

Breaks if: This Neutral tips Cautious if revenue growth falls below 4% for two consecutive reported quarters, or if free cash flow margin slips below 14% on the next two prints — either would signal the recovery has stalled at a multiple that prices in considerably better. It tips Positive if revenue growth reaches 10% or more for two consecutive quarters while free cash flow runs at or above $1.35 billion on a trailing basis — that pace would suggest a re-acceleration the current multiple has not fully captured.

Key figures

Market value$48.0B
Revenue, last 12 months$7.4B
Net income, last 12 months$1.4B
Free cash flow, last 12 months$1.3B
Price to earnings33.4×
Free cash flow yield2.6%
Dividend yield0.6%
Operating margin22.2%
Return on equity21.0%
Beta to the S&P 5000.93
Volatility, annualized31.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
July 31, 2026$1.9B8.1%$1.28$439M
April 30, 2026$1.8B10.0%$1.20$201M
January 31, 2026$1.8B7.0%$1.07$175M
October 31, 2025$1.9B9.4%$1.52$452M
July 31, 2025$1.7B10.1%$1.18$259M
April 30, 2025$1.7B6.0%$0.75$107M
January 31, 2025$1.7B1.4%$1.11$334M
October 31, 2024$1.7B0.8%$1.23$388M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

8 ledger entries and 39 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.